awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35051393-63CF9478-F2F8-4ABA-8211-66B4568CAEA0
Q35051393-63CF9478-F2F8-4ABA-8211-66B4568CAEA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35051393-63CF9478-F2F8-4ABA-8211-66B4568CAEA0
What if HIV were unable to develop resistance against a new therapeutic agent?
P2860
Q35051393-63CF9478-F2F8-4ABA-8211-66B4568CAEA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35051393-63CF9478-F2F8-4ABA-8211-66B4568CAEA0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1c6cfc2de4770b63db39b4085380817ae1393334
P2860
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.